Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients

MLA

Lavoie, Suzie, et al. Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients. 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1133753498&authtype=sso&custid=ns315887.

APA

Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., Fornari, E., Meuli, R., Solida, A., Vianin, P., Cuénod, M., Buclin, T., & Do, K. Q. (2008). Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients.

Chicago

Lavoie, Suzie, Micah M. Murray, Patricia Deppen, Maria G. Knyazeva, Michael Berk, Olivier Boulat, Pierre Bovet, et al. 2008. “Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1133753498&authtype=sso&custid=ns315887.